President Trump signed the bill into law in the Oval Office after the House voted to pass the funding measure earlier in the evening.

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced its business update and financial results for the first nine months of 2025. "This quarter highlights ...